The fight over healthcare is not over.Today’s decision means that state lawmakers will have to pass legislation to establish insurance exchange that will allow uninsured people and small businesses to access quality healthcare coverage at affordable prices. If the state Legislature fails to do so, people will have to buy insurance through a federally created …
This abstract was recently presented at the International Workshop on HIV and Hepatitis in Sitges Abstract 37 by RF Schinazi and colleagues was on the topic of a novel series of inhibitors of HIV replication called Jak inhibitors. These compounds are able to interfere with the Jak-STAT pathway in activated lymphocytes and macrophages in the aftermath of …
Exciting New Data on The Use of JAK Inhibitors to Control HIV Read More »
If the process for developing HIV drugs has been unusual, selling them has been even more so. America is the rich world’s biggest market, with 841,000 patients diagnosed—ten times as many as in Britain. More than 60% of HIV drugs in America are bought with public money. Insurers give HIV special treatment: patients are rarely …
The Economist: The business of HIV – Battling the virus- A huge, strange drug market Read More »
Some HIV+ people have emailed me worried about this report: Heart Attacks Found Early and Frequently in HIV Positive People Calculate your 5 year estimated cardiovascular risk: D-A-D Cardiovascular Risk Equation for HIV+ People My suggestions to minimize heart disease (not in any other of importance): 1- Do not smoke 2- Keep your cholesterol and triglycerides within normal ranges …
I want to congratulate the Stigma Project (https://www.thestigmaproject.org ) for their great campaigns to fight stigma. I particularly love this last ad called “Clean UB2” On the internet, HIV negative (or those who do not know their status) often refer to themselves as “clean” or DDF (drug and disease free), two terms that really stigmatize HIV …
https://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/3629-nrti-sparing-art-with-atazanavir-raltegravir-conflicting-data-for-naive-and-experienced-patients NRTI-sparing antiretroviral regimen of unboosted atazanavir (Reyataz) plus raltegravir (Isentress) suppresses HIV in treatment-naive patients as well as standard 3-drug combinations, but its twice-daily dosing, side effects, and low barrier to resistance limit its appeal. For treatment-experienced people already doing well on atazanavir triple therapy, however, the dual regimen may be an attractive simplification …
Sign this Petition to Ask Obama for More HIV Cure Research Funding
Nelson, How is Timothy Brown doing? Jun 13, 2012 I have read some of your post about Timothy Brown, the guy who was cured of HIV. I was shocked to find out he has been struggling here in the United States after he moved from Germany. How is he doing now? How is his health? …
Nelson, how is the man who got cured of HIV (The Berlin Patient) doing ? Read More »
A class of HIV antiretroviral drugs known as CCR5 antagonists — which includes maraviroc (Selzentry) and vicriviroc — inhibit the invasion or spread of specific types of breast cancer cells that express CCR5 receptors, according to findings from a laboratory study published in the May 25, 2012, advance online edition of Cancer Research. Click here …
Staying on top of your treatment every day is not an easy task. Annoying side effects, being disorganized and the hustle and bustle of life can stand in your way. So we took to the streets to ask HIV experts and people living with HIV to talk about why adherence is important and to share …
Tips from Long Term Survivors for Taking Your Medications on Time Read More »
